Avidity Biosciences Announces Intention to Adjourn and Reconvene Special Meeting of Stockholders

Avidity Biosciences Announces Intention to Adjourn and Reconvene Special Meeting of Stockholders [Accessibility Statement] Skip NavigationSAN DIEGO, Feb. 23, 2026 /PRNewswire/ -- Avidity Biosciences, Inc. ("Avidity") (NASDAQ: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates ("AOCsâ"¢") to profoundly improve people's lives, today announced that it intends to convene its upcoming special meeting of stockholders (the "Special M ...